ALB and chronic obstructive pulmonary disease: Studies have demonstrated that hematologic inflammatory biomarkers obtained from routine blood tests, such as the neutrophil-percentage-to-albumin ratio (NPAR), the platelet-to-lymphocyte ratio (PLR), and the neutrophil-to-lymphocyte ratio (NLR), have shown significant associations with mortality in patients with COPD (3, 4).